Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
Abstract Introduction Previous works of literatures on the viral load suppression rate of third line antiretroviral therapy in Africa has produced inconsistent and inconclusive results, with rates varying between 62% and 95%. This variability poses challenges for policymakers and healthcare provider...
Saved in:
Main Authors: | Tilahun Degu Tsega, Sintayehu Simie Tsega, Asaye Alamneh Gebeyehu, Getaneh Atikilt Yemata, Rahel Mulatie Anteneh, Almaw Genet Yeshiwas, Getasew Yirdaw, Chalachew Yenew, Anley Shiferaw Enawgaw, Amare Genetu Ejigu, Ahmed Fentaw Ahmed, Zeamanuel Anteneh Yigzaw, Berhanu Abebaw Mekonnen, Meron Asmamaw Alemayehu, Abathun Temesgen, Abebaw Molla, Habitamu Mekonen, Assefa Andargie Kassa, Gashaw Melkie Bayeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-025-10576-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction model for unfavorable treatment outcome for complicated sever acute malnutrition (SAM) in under five children admitted in hospitals at Amhara Region
by: Almaw Genet Yeshiwas, et al.
Published: (2025-02-01) -
A Review on Biohazards Removal in Ethiopia: Efficacy of Existing Treatment Systems and Challenges
by: Chalachew Yenew, et al.
Published: (2025-01-01) -
Assessment of Factors Affecting Time to Recovery from COVID-19: A Retrospective Study in Ethiopia
by: Anteneh Mengist Dessie, et al.
Published: (2022-01-01) -
Maternity Continuum Care Completion and Its Associated Factors in Northwest Ethiopia
by: Daniel Tsega, et al.
Published: (2022-01-01) -
Prevalence of depressive symptom and its associated factors among epilepsy patients in Amhara region, Ethiopia: cross-sectional study
by: Sintayehu Simie Tsega, et al.
Published: (2025-01-01)